Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Multiple Myeloma: Elderly Patients

Multiple Myeloma: Elderly Patients

Multiple Myeloma: High Risk Cytogenetics

Multiple Myeloma: High Risk Cytogenetics

Multiple Myeloma: Renal Impairment

Multiple Myeloma: Renal Impairment

Lenalidomide Refractory Patients

Lenalidomide Refractory Patients

Multiple Myeloma: Minimal Residual Disease

Multiple Myeloma: Minimal Residual Disease

Multiple Myeloma: Chromosome 1q+ cytogenetic abnormalities

Multiple Myeloma: Chromosome 1q+ cytogenetic abnormalities

An overview of Lysosomal Storage Disorders & Sanofi`s Commitment to the Development and Provision of Treatments

An overview of Lysosomal Storage Disorders & Sanofi`s Commitment to the Development and Provision of Treatments

Patients Factors & Impacts

Patients Factors & Impacts

Myeloma Facts

Myeloma Facts

Prevalence of Asthma

Prevalence of Asthma

Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials

Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials

Experts recommendations on Late Onset Pompe Disease (LOPD) differential diagnosis from GCC

Experts recommendations on Late Onset Pompe Disease (LOPD) differential diagnosis from GCC